BioCentury
ARTICLE | Company News

BTG, Nordion deal

July 22, 2013 7:00 AM UTC

BTG completed its acquisition of Therasphere liver cancer therapy from Nordion for $200 million. The yttrium-90 glass microspheres used for localized radioembolization therapy is approved in Europe a...